Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 96, Issue 1, Pages 183-193Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2015.05.018
Keywords
alpha(v)beta(3); Cancer; Bone metastasis; Target therapy; Multiple myeloma
Categories
Funding
- AIRC (Italian Association for Cancer Research) [IG11647]
Ask authors/readers for more resources
The interplay of cancer cells and accessory cells within the microenvironment drives signals regulating the proliferation, migration and skeleton colonization. Osteotropism of tumor cells depends on chemoldne activation, production of soluble factors and defective gene expression that cooperate within the metastatic niche to the bone resorbing functions of osteoclasts. Adhesion of cancer cells to the extracellular matrix is regulated by integrins as alpha(v)beta(3) that enhances their invasiveness, pro-tumor angiogenesis and skeleton invasion. Therefore, alpha(v)beta(3) signaling is implicated in enhancing osteotropism of breast and prostate cancers as well as of multiple myeloma. Targeting of alpha(v)beta(3) has been adopted to restrain the tumor progression in several cancer models leading to improvement of overall survival as effect of the reduction of both tumor burden and osteotropism by malignant cells. Here, we review both the role of alpha(v)beta(3) in malignant osteoclastogenesis and its potential targeting to restrain the bone colonization by skeleton invading cancers. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available